Shares of Novavax plunged Wednesday morning after a report highlighted manufacturing problems that imperil the company's ability to produce billions of Covid-19 vaccine doses earmarked for lower-income countries, making it the latest vaccine-maker posting staggering losses in the stock market after massive gains during the pandemic.
